This author has not written his bio yet.
But we are proud to say that san1Admn contributed 199 entries already.
SANEMUS is supporting a diagnostics start-up focused on the identification and characterization of circulating tumor cells (CTC) in finding new investors. The start-up has developed a patent-protected innovative diagnostic system, which is able to identify all CTCs with higher sensitivity and specificity and faster throughput compared to current systems on the market. The address of […]
The SANEMUS team supervises a biotech start-up in attracting venture capital, which has developed a proprietary technology platform for the encapsulation of nucleid acids (siRNA, mRNA) as well as low molecular compounds. The goal is the development of new RNA drugs in cancer therapy and the therapy of genetic defects. Talks are currently taking place […]
A German family office in the field of plant manufacturing has again invested tens of millions in an European Life Science VC fund on the recommendation of SANEMUS AG. At that time, SANEMUS prepared an overview of the healthcare market with its investment opportunities for the family office, which was the basis for the investment […]
Dr. Thiel, Partner at Sanemus AG, gave a lecture at the University of Maastricht, Management School, on May 8th, 2017. In his lecture, his main topic was the question: “Which sort of qualification is needed to succesfully establish a start-up?” If you want to know more about the presentation of Dr. Michael Thiel and if you […]
In his article “Life Sciences Venture Capital-funds on the rise” in the april issue of VentureCapital magazine, Dr. Thiel reports about the success of European Life Sciences Venture Capital funds in 2016. Many large funds, such as the Endeavour Vision III-fund and Life Science Partners V-fund raised more than 200 mio. euros. Particulary pleasing from […]
Exact Imaging Inc. (Toronto), a Canadian Medtech Start-Up, successfully closed its Series C Financing Round on December 22nd 2016 at the amount of CAD 21.5 Mio. (15.4 Mio. €). SANEMUS AG was in charge of finding the European investors. Please find more information in the press release
The SANEMUS team supports a second Canadian medtech Start-Up for raising venture capital. The Start-Up has developed a non-invasive device to prevent reperfusion injuries caused by ischemia. The team is currently actively searching co-investors in Europe.
Our team supports a Canadian medtech Start-Up for the fundraising. The Start-Up has developed a high-resolution ultrasound technology for the identification of tumor tissue during a prostate biopsy. An European lead-investor could be identified. The team is currently in the process of putting the investors syndicate together.
The SANEMUS team supports a German mid-sized pharmaceutical company for its strategic redirection. The focus lies on the elaboration of strategic options for an expansion of its business to ensure a sustainable growth in the future. Portfolio optimization, in and out licensing of products as well as the optimal marketing and sales support of the new portfolio […]
Our team supports a mid-sized German pharmaceutical company for the elaboration of a relaunch strategy for an oncology drug. The main focus is on preparing a commercially attractive business case for the relaunch. Moreover the implementation of the future marketing and sales strategy will be supervised.
SANEMUS AG
Mannhardtstraße 6
80538 München
T +49 (0)171 60 32 076
info(at)sanemus(dot)com